|  	| 
 | TABLE OF CONTENTS 
 |  |  |  |  |  | Volume 23, Issue 1 (January 2016) |  |  | In this issue 
  Original Article – Enabling Technologies 
  Original Articles 
  Short Communications 
 Also new
 
     AOP |  |  |  |  |  |  | Original Article – Enabling Technologies |  Top |  |  |  | Noninvasive tracking of gene transcript and neuroprotection after gene therapyJ Ren,  Y I Chen,  C H Liu,  P-C Chen,  H Prentice,  J-Y Wu and  P K Liu Gene Ther 2016 23: 1-9; advance online publication, July 24, 2015; 10.1038/gt.2015.81 Abstract | Full Text |  |  |  | Original Articles |  Top |  |  |  | In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expressionA Rashnonejad,  C Gündüz,  S Y Süslüer,  H Onay,  B Durmaz,  M Bandehpour and  F Özkınay Gene Ther 2016 23: 10-17; advance online publication, September 2, 2015; 10.1038/gt.2015.92 Abstract | Full Text |  |  |  |  |  |  |  | Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cellsR Sayroo,  D Nolasco,  Z Yin,  Y Colon-Cortes,  M Pandya,  C Ling and  G Aslanidi Gene Ther 2016 23: 18-25; advance online publication, October 8, 2015; 10.1038/gt.2015.89 Abstract | Full Text |  |  |  |  |  |  |  | Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigsB Grubor-Bauk,  W Yu,  D Wijesundara,  J Gummow,  T Garrod,  A J Brennan,  I Voskoboinik and  E J Gowans Gene Ther 2016 23: 26-37; advance online publication, October 1, 2015; 10.1038/gt.2015.86 Abstract | Full Text |  |  |  |  |  |  |  | Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulatorM-C Chang,  Y-L Chen,  Y-C Chiang,  T-C Chen,  Y-C Tang,  C-A Chen,  W-Z Sun and  W-F Cheng Gene Ther 2016 23: 38-49; advance online publication, August 11, 2015; 10.1038/gt.2015.85 Abstract | Full Text |  |  |  |  |  |  |  | Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beamsM Kano,  K Matsushita,  B Rahmutulla,  S Yamada,  H Shimada,  S Kubo,  T Hiwasa,  H Matsubara and  F Nomura Gene Ther 2016 23: 50-56; advance online publication, August 4, 2015; 10.1038/gt.2015.84 Abstract | Full Text |  |  |  |  |  |  |  | β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E miceE R Pozsgai,  D A Griffin,  K N Heller,  J R Mendell and  L R Rodino-Klapac Gene Ther 2016 23: 57-66; advance online publication, August 20, 2015; 10.1038/gt.2015.80 Abstract | Full Text |  |  |  |  |  |  |  | Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinomaÁ J De la Rosa,  Á Rodríguez-Hernández,  R González,  S Romero-Brufau,  E Navarro-Villarán,  L Barrera-Pulido,  S Pereira,  L M Marín,  F López-Bernal,  J M Álamo,  M A Gómez-Bravo,  F J Padillo and  J Muntané Gene Ther 2016 23: 67-77; advance online publication, July 23, 2015; 10.1038/gt.2015.79 Abstract | Full Text |  |  |  |  |  |  |  | Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR−/− miceG Li,  C Chen,  S D Laing,  C Ballard,  K C Biju,  R L Reddick,  R A Clark and  S Li Gene Ther 2016 23: 78-85; advance online publication, August 23, 2015; 10.1038/gt.2015.78 Abstract | Full Text |  |  |  |  |  |  |  | Evaluation of helper-dependent canine adenovirus vectors in a 3D human CNS modelD Simão,  C Pinto,  P Fernandes,  C J Peddie,  S Piersanti,  L M Collinson,  S Salinas,  I Saggio,  G Schiavo,  E J Kremer,  C Brito and  P M Alves Gene Ther 2016 23: 86-94; advance online publication, August 20, 2015; 10.1038/gt.2015.75 Abstract | Full Text |  |  |  |  |  |  |  | AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy OPENM E Yalvac,  W D Arnold,  C Braganza,  L Chen,  J R Mendell and  Z Sahenk Gene Ther 2016 23: 95-102; advance online publication, June 30, 2015; 10.1038/gt.2015.67 Abstract | Full Text |  |  |  | Short Communications |  Top |  |  |  | Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigen-presenting cellsB Walch-Rückheim,  R Kiefer,  G Geginat,  M J Schmitt and  F Breinig Gene Ther 2016 23: 103-107; advance online publication, August 20, 2015; 10.1038/gt.2015.77 Abstract | Full Text |  |  |  |  |  |  |  | CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting OPEND G Courtney,  J E Moore,  S D Atkinson,  E Maurizi,  E H A Allen,  D M L Pedrioli,  W H I McLean,  M A Nesbit and  C B T Moore Gene Ther 2016 23: 108-112; advance online publication, August 20, 2015; 10.1038/gt.2015.82 Abstract | Full Text |  |  |  |  |  |  |  | Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR OPENI Christodoulou,  P Patsali,  C Stephanou,  M Antoniou,  M Kleanthous and  C W Lederer Gene Ther 2016 23: 113-118; advance online publication, June 30, 2015; 10.1038/gt.2015.60 Abstract | Full Text |  |  |  |  |  |  |       |  |       |      	     		|  |       		|  |  |  |       		|  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. 
 Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
 |  |  |       		|  |  |  |  |       |  |   	| Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices:London - Paris - Munich - New Delhi - Tokyo - Melbourne
 San Diego - San Francisco - Washington - New York - Boston
 Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |   	|  |   	|  | 
 |  | 
No comments:
Post a Comment